Evidence map›Paper›PMID 19393694›Full record

ArticleBiochimica et biophysica acta2009

Ceramide synthase 1 is regulated by proteasomal mediated turnover.

Priya Sridevi, Hannah Alexander, Elad L Laviad, Yael Pewzner-Jung, Mark Hannink, Anthony H Futerman, Stephen Alexander

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Therapeutic Potential of Ceramide in Cancer Treatment.Journal of cancer research and oncobiology · 2024
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Sphingolipids and mitochondrial apoptosis.Journal of bioenergetics and biomembranes · 2016
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Modulation of ceramide synthase activity via dimerization.The Journal of biological chemistry · 2012
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Priya SrideviDivision of Biological Sciences, University of Missouri, Columbia, MO 65211, USA.
Hannah Alexander
Elad L Laviad
Yael Pewzner-Jung
Mark Hannink
Anthony H Futerman
Stephen Alexander
University of Missouri · USWeizmann Institute of Science · IL

Funding

Role of a Novel E3-Ubiquitin Ligase in ChemopreventionR01AT003899 · NCCIH · UNIVERSITY OF MISSOURI-COLUMBIA · PI HANNINK, MARK · 2006 to 2009
$1.8M
Signaling response to DNA damage in DictyosteliumR01GM053929 · NIGMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI ALEXANDER, STEPHEN · 1996 to 2005
$1.1M
NCCIH NIH HHS AT003899NCCIH NIH HHS R01 AT003899NIGMS NIH HHS GM53929NIGMS NIH HHS R01 GM053929
6 · The paper itself

Abstract

Ceramide is an important bioactive lipid, intimately involved in many cellular functions, including the regulation of cell death, and in cancer and chemotherapy. Ceramide is synthesized de novo from sphinganine and acyl CoA via a family of 6 ceramide synthase enzymes, each having a unique preference for different fatty acyl CoA substrates and a unique tissue distribution. However, little is known regarding the regulation of these important enzymes. In this study we focus on ceramide synthase 1 (CerS1) which is the most structurally and functionally distinct of the enzymes, and describe a regulatory mechanism that specifically controls the level of CerS1 via ubiquitination and proteasome dependent protein turnover. We show that both endogenous and ectopically expressed CerS1 have rapid basal turnover and that diverse stresses including chemotherapeutic drugs, UV light and DTT can induce CerS1 turnover. The turnover requires CerS1 activity and is regulated by the opposing actions of p38 MAP kinase and protein kinase C (PKC). p38 MAP kinase is a positive regulator of turnover, while PKC is a negative regulator of turnover. CerS1 is phosphorylated in vivo and activation of PKC increases the phosphorylation of the protein. This study reveals a novel and highly specific mechanism by which CerS1 protein levels are regulated and which directly impacts ceramide homeostasis.

Indexed as

Gene Expression Regulation, EnzymologicCells, CulturedHumansImmunoblottingImmunoprecipitationKidneyOxidoreductasesp38 Mitogen-Activated Protein KinasesPhosphorylationProteasome Endopeptidase ComplexProtein Kinase CSignal TransductionUbiquitindihydroceramide desaturaseOxidoreductasesp38 Mitogen-Activated Protein KinasesProteasome Endopeptidase ComplexProtein Kinase CUbiquitin

Identifiers

PMID19393694
PMCPMC2724657
OpenAlexW2027849182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.